Oric PharmaceuticalsORIC

那斯達克 · USD
8.32
-0.14
(-1.65%)
收盤 05/23 03:59 (UTC+8)
盤後 
8.45 
+0.13 
(+1.56%)
05/23 03:59 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
icon
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2026/Q1
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
營業收入淨額
-
-
-
-
-
-
-
-
-
-
營業成本
----------
營業毛利
-
-
-
-
-
-
-
-
-
-
營業費用
39,61934,55136,67139,06432,71839,570-36,01728,99031,428
研發費用
31,43725,85628,77330,54924,64031,97031,20228,94021,96024,481
推銷及管理費用
8,1828,6957,8988,5158,0787,6007,1167,0777,0306,947
非經常性項目費用
----------
其他營業費用
----------
營業利益
-39,619
-34,551
-36,671
-39,064
-32,718
-39,570
-38,318
-36,017
-28,990
-31,428
其他收入及費用
3,8524,0464,0842,7092,6973,2633,7524,0543,9793,098
利息費用
----------
稅前純益
-35,767
-30,505
-32,587
-36,355
-30,021
-36,307
-34,566
-31,963
-25,011
-28,330
所得稅
----------
稅後純益
-35,767
-30,505
-32,587
-36,355
-30,021
-36,307
-34,566
-31,963
-25,011
-28,330
基本每股稅後盈餘(元)
-0.34-0.30-0.33-0.47-0.42-0.51-0.49-0.45-0.37-
稀釋每股稅後盈餘(元)
-0.34-0.27-0.33-0.47-0.42-0.51-0.49-0.46-0.37-0.50
基本平均股數(千股)
105472.00102585.0098953.0078126.0071040.0070652.0070542.0070348.0067349.00-
稀釋平均股數(千股)
105472.00102585.0098953.0078126.0071040.0070652.0070542.0070348.0067349.00-
還原基本每股稅後盈餘(元)
-0.34-0.30-0.33-0.47-0.42-0.51-0.49-0.45-0.37-
還原稀釋每股稅後盈餘(元)
-0.34-0.27-0.33-0.47-0.42-0.51-0.49-0.46-0.37-0.50
還原基本平均股數(千股)
105,472102,58598,95378,12671,04070,65270,54270,34867,349-
還原稀釋平均股數(千股)
105,472102,58598,95378,12671,04070,65270,54270,34867,349-
EBITDA(千元)
-35,335-30,425-32,886-36,636-30,601-37,637-36,242-33,987-26,977-30,190

大家都在看

HOT